Objective: This Host paper (III of V) reviews key surveillance and evaluation systems that monitor the characteristics, attitudes and behaviors of tobacco users that are crucial for tobacco control efforts.

Methods: We summarize and expand on the recommendations from the Host Working Group of the National Tobacco Monitoring, Research and Evaluation Workshop. We also discuss research challenges and make additional recommendations for improving tobacco control surveillance and evaluation.

Results: We reviewed 10 major US surveys that collect data on tobacco use. A great deal of data is collected but gaps exist. Data collection on cigars, smokeless tobacco, brand, menthols, and PREPs is sparse and infrequent. Also, a number of factors, including, but not limited to, changes in US population composition, declines in survey response rates, and increases in cell phone use present research challenges that may impact the ongoing utility of these systems.

Conclusions: Although the field of tobacco control research is an advanced area of public health, improvements in data systems are necessary to accurately evaluate progress and continue tobacco control gains. A coordinated surveillance and evaluation network would increase efficiency and improve the overall utility, quality and timeliness of the current data systems.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ypmed.2008.09.008DOI Listing

Publication Analysis

Top Keywords

tobacco control
16
surveillance evaluation
8
tobacco
8
data systems
8
data
6
monitoring tobacco
4
tobacco epidemic
4
epidemic iii
4
iii host
4
host data
4

Similar Publications

Background: Tobacco advertisements or promotions (TAPs) can increase smoking susceptibility, especially among adolescents.China has made great progress in reducing TAPs, but has not yet achieved a total ban.This study estimated exposure to TAPs and smoking susceptibility and their changes from 2013-14 to 2021 among Chinese adolescents and examined their association.

View Article and Find Full Text PDF

Background: Tobacco use is a known modifiable risk factor for postoperative complications and revision surgery after anterior cruciate ligament reconstruction (ACLR). Previous studies focus on tobacco as a broad categorization of traditional smoking, smokeless tobacco, and other forms of nicotine use. It is unclear if differences in the type of nicotine used lead to similar adverse outcomes after ACLR.

View Article and Find Full Text PDF

Background: Smoking rates in the UK have declined steadily over the past decades, masking considerable inequalities, as little change has been observed among people with a mental health condition. This trial sought to assess the feasibility and acceptability of supplying an electronic cigarette (e-cigarette) starter kit for smoking cessation as an adjunct to usual care for smoking cessation, to smokers with a mental health condition treated in the community, to inform a future effectiveness trial.

Methods: This randomised controlled feasibility trial, conducted March-December 2022, compared the intervention (e-cigarette starter kit with a corresponding information leaflet and demonstration with Very Brief Advice) with a 'usual care' control at 1-month follow-up.

View Article and Find Full Text PDF

The health implications of engaging in risk-taking or protective behaviors can have long-lasting effects on an individual's life. In recent years, there has been a growing interest in how religious attitudes and beliefs influence an individual's health behaviors. However, research on the role of the God Locus of Health Control (GLHC) in the religion-health literature is lacking.

View Article and Find Full Text PDF

In 2024, Philip Morris International's (PMI) website stated they support 'independent' continuing medical education courses on harm reduction for medical and other healthcare professionals. These courses mirrored industry marketing and political strategies by presenting smokeless tobacco products and e-cigarettes as alternatives to smoking, sometimes without mentioning tobacco cessation. The enactment of the US Family Smoking and Tobacco Control Act gave the US Food and Drug Agency jurisdiction over tobacco products and included the industry's 'continuum of risk' frame, and emboldened tobacco companies to make harm reduction claims about these products, which they had previously avoided for fear of triggering restrictive regulation of cigarettes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!